Annual Report 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Corporate Governance Statement,
Reporting Period Jan. 1–Dec. 31, 2017
 

Seppo Mäkinen

b. 1952, M.Sc. Physical Chemistry
Full-time occupation: Professional Board Member 

Positions of trust:

  • Bittium Corporation, Member of the Board 2015–.
  • Pathena S.A., Partner 2017–.
  • ValiRx Plc, Member of the Board 2013–2017, Advisor 2017–.
  • Evondos Oy, Member of the Board 2016–.
  • CBRA Genomics S.A., Member of the Board 2016–.
  • Neurotar Oy, Member of the Board 2015–.
  • MedGroup Oy, Member of the Board 2013–.
  • Ginolis Oy, Member of the Board 2011–, Chairman of the Board 2011–2014.

Previous work history:

  • Taikon Advisor, Managing Partner 2010–2016.
  • Merieux Développement, Regional Partner, Nordics 2010–2016.
  • Ventac Partners, Partner 2012–2016.
  • Magnasense Technologies Oy, Member of the Board 2011–2015.
  • Arcdia International Oy, Member of the Board 2011–2014.
  • Balonco, Senior Advisor, owner 2012–2013.
  • Mediracer Ltd., Chairman of the Board 2010–2013.
  • RSP Systems, Member of the Board 2010–2011.
  • Bio Fund Management Oy, Founding/ Managing Partner 1997–2010.
  • Sitra, Director in Life Science 1987–1997.
  • Millipore/ Waters, Sales & Marketing 1983–1987.
  • State Institute of Agricultural Chemistry, Chemist 1980–1983.
  • Served as a Chairman or Member of the Board in Egalet A/S, SpinX Inc., Chempaq, Profos AG, Ilochip A/S, Exiqon A/S, KSH-Productor Oy, Merlin Diagnostika GmbH, Primex ASA, Rumen Oy, Millimed Inc., BioPorto A/S, Wallac, Kone Instruments, Rados Technologies, MAP Medical Technologies, Pharming NV, Bio-Orbit, Labmaster Oy, Viable Bioproducts and Fluilogic Oy.

Holdings Dec. 31, 2017:
Holds 2,871 shares in Bittium Corporation.

Independent as regards both the Company and its significant shareholders.